A Comparative Study: The Use of Collagen Implant versus Mitomycin-C in Combined Trabeculotomy and Trabeculectomy for Treatment of Primary Congenital Glaucoma

Purpose. To compare Ologen implant versus mitomycin-C (MMC) in combined trabeculotomy and trabeculectomy as a treatment of primary congenital glaucoma. Setting. Sohag University Hospital, Egypt. Design. A prospective comparative study. Methods. Thirty-four eyes of twenty-one patients with primary co...

Full description

Saved in:
Bibliographic Details
Main Authors: Alaa Abdel Sadek Singab, Osama Ali Mohammed, Mohammed Iqbal Hafez Saleem, Mortada Ahmed Abozaid
Format: Article
Language:English
Published: Wiley 2017-01-01
Series:Journal of Ophthalmology
Online Access:http://dx.doi.org/10.1155/2017/9241459
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832549596052586496
author Alaa Abdel Sadek Singab
Osama Ali Mohammed
Mohammed Iqbal Hafez Saleem
Mortada Ahmed Abozaid
author_facet Alaa Abdel Sadek Singab
Osama Ali Mohammed
Mohammed Iqbal Hafez Saleem
Mortada Ahmed Abozaid
author_sort Alaa Abdel Sadek Singab
collection DOAJ
description Purpose. To compare Ologen implant versus mitomycin-C (MMC) in combined trabeculotomy and trabeculectomy as a treatment of primary congenital glaucoma. Setting. Sohag University Hospital, Egypt. Design. A prospective comparative study. Methods. Thirty-four eyes of twenty-one patients with primary congenital glaucoma were included in this study. All patients were subjected to preoperative evaluation including complete anterior segment examination under general anesthesia. The patients were divided into two groups: patients of the first group (group A) underwent combined trabeculotomy and trabeculectomy with Ologen implantation while those of the second group (group B) underwent combined trabeculotomy and trabeculectomy with MMC application. Results. Postoperatively, the IOP in group A was as follows: 8 eyes developed IOP levels less than 14 mmHg (complete success), 3 eyes had levels between 14 and 16 mmHg (accepted result), 2 eyes had levels between 16 and 20 mmHg (guarded result), and only 2 eyes showed levels exceeding 20 mmHg (failed procedure), while in group B, 7 eyes showed complete success, 3 eyes had accepted result, 3 eyes had guarded result, and 2 eyes had failed procedure. Conclusion. Ologen is a safe and effective adjuvant in combined trabeculotomy and trabeculectomy for treatment of primary congenital glaucoma.
format Article
id doaj-art-90997d66854e49d0a232efad4148eb1c
institution Kabale University
issn 2090-004X
2090-0058
language English
publishDate 2017-01-01
publisher Wiley
record_format Article
series Journal of Ophthalmology
spelling doaj-art-90997d66854e49d0a232efad4148eb1c2025-02-03T06:10:56ZengWileyJournal of Ophthalmology2090-004X2090-00582017-01-01201710.1155/2017/92414599241459A Comparative Study: The Use of Collagen Implant versus Mitomycin-C in Combined Trabeculotomy and Trabeculectomy for Treatment of Primary Congenital GlaucomaAlaa Abdel Sadek Singab0Osama Ali Mohammed1Mohammed Iqbal Hafez Saleem2Mortada Ahmed Abozaid3Ophthalmology Department, Sohag University, Sohag, EgyptOphthalmology Department, Sohag University, Sohag, EgyptOphthalmology Department, Sohag University, Sohag, EgyptOphthalmology Department, Sohag University, Sohag, EgyptPurpose. To compare Ologen implant versus mitomycin-C (MMC) in combined trabeculotomy and trabeculectomy as a treatment of primary congenital glaucoma. Setting. Sohag University Hospital, Egypt. Design. A prospective comparative study. Methods. Thirty-four eyes of twenty-one patients with primary congenital glaucoma were included in this study. All patients were subjected to preoperative evaluation including complete anterior segment examination under general anesthesia. The patients were divided into two groups: patients of the first group (group A) underwent combined trabeculotomy and trabeculectomy with Ologen implantation while those of the second group (group B) underwent combined trabeculotomy and trabeculectomy with MMC application. Results. Postoperatively, the IOP in group A was as follows: 8 eyes developed IOP levels less than 14 mmHg (complete success), 3 eyes had levels between 14 and 16 mmHg (accepted result), 2 eyes had levels between 16 and 20 mmHg (guarded result), and only 2 eyes showed levels exceeding 20 mmHg (failed procedure), while in group B, 7 eyes showed complete success, 3 eyes had accepted result, 3 eyes had guarded result, and 2 eyes had failed procedure. Conclusion. Ologen is a safe and effective adjuvant in combined trabeculotomy and trabeculectomy for treatment of primary congenital glaucoma.http://dx.doi.org/10.1155/2017/9241459
spellingShingle Alaa Abdel Sadek Singab
Osama Ali Mohammed
Mohammed Iqbal Hafez Saleem
Mortada Ahmed Abozaid
A Comparative Study: The Use of Collagen Implant versus Mitomycin-C in Combined Trabeculotomy and Trabeculectomy for Treatment of Primary Congenital Glaucoma
Journal of Ophthalmology
title A Comparative Study: The Use of Collagen Implant versus Mitomycin-C in Combined Trabeculotomy and Trabeculectomy for Treatment of Primary Congenital Glaucoma
title_full A Comparative Study: The Use of Collagen Implant versus Mitomycin-C in Combined Trabeculotomy and Trabeculectomy for Treatment of Primary Congenital Glaucoma
title_fullStr A Comparative Study: The Use of Collagen Implant versus Mitomycin-C in Combined Trabeculotomy and Trabeculectomy for Treatment of Primary Congenital Glaucoma
title_full_unstemmed A Comparative Study: The Use of Collagen Implant versus Mitomycin-C in Combined Trabeculotomy and Trabeculectomy for Treatment of Primary Congenital Glaucoma
title_short A Comparative Study: The Use of Collagen Implant versus Mitomycin-C in Combined Trabeculotomy and Trabeculectomy for Treatment of Primary Congenital Glaucoma
title_sort comparative study the use of collagen implant versus mitomycin c in combined trabeculotomy and trabeculectomy for treatment of primary congenital glaucoma
url http://dx.doi.org/10.1155/2017/9241459
work_keys_str_mv AT alaaabdelsadeksingab acomparativestudytheuseofcollagenimplantversusmitomycincincombinedtrabeculotomyandtrabeculectomyfortreatmentofprimarycongenitalglaucoma
AT osamaalimohammed acomparativestudytheuseofcollagenimplantversusmitomycincincombinedtrabeculotomyandtrabeculectomyfortreatmentofprimarycongenitalglaucoma
AT mohammediqbalhafezsaleem acomparativestudytheuseofcollagenimplantversusmitomycincincombinedtrabeculotomyandtrabeculectomyfortreatmentofprimarycongenitalglaucoma
AT mortadaahmedabozaid acomparativestudytheuseofcollagenimplantversusmitomycincincombinedtrabeculotomyandtrabeculectomyfortreatmentofprimarycongenitalglaucoma
AT alaaabdelsadeksingab comparativestudytheuseofcollagenimplantversusmitomycincincombinedtrabeculotomyandtrabeculectomyfortreatmentofprimarycongenitalglaucoma
AT osamaalimohammed comparativestudytheuseofcollagenimplantversusmitomycincincombinedtrabeculotomyandtrabeculectomyfortreatmentofprimarycongenitalglaucoma
AT mohammediqbalhafezsaleem comparativestudytheuseofcollagenimplantversusmitomycincincombinedtrabeculotomyandtrabeculectomyfortreatmentofprimarycongenitalglaucoma
AT mortadaahmedabozaid comparativestudytheuseofcollagenimplantversusmitomycincincombinedtrabeculotomyandtrabeculectomyfortreatmentofprimarycongenitalglaucoma